
조혜연 교수
031-8086-2650


부인암 (난소암, 자궁경부암, 자궁내막암), 자궁근종, 난소낭종, 자궁내막증, 복강경수술, 로봇수술, 단일공 로봇수술, 자궁내시경 수술
| 진료시간 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 오전 | ||||||
| 오후 | 외래진료 |
한림대학교 의과대학 졸업 한림대학교 일반대학원 의학과 석사 서울대학교 일반대학원 의과대학 산부인과학 박사 |
2007 ~ 2011한림대학교강남성심병원 산부인과 전공의 수료 2011 ~ 2012분당서울대병원 산부인과 부인종양학 임상강사 2012 ~ 2014한림대학교동탄성심병원 산부인과 부인종양학 임상강사 2014 ~ 2016한림대학교동탄성심병원 산부인과 임상조교수 2016 ~ 2021한림대학교동탄성심병원 산부인과 조교수 2022 ~ 한림대학교동탄성심병원 산부인과 부교수 |
대한부인종양학회 대한산부인과학회 유럽 내시경학회 대한산부인과 로봇수술학회 편집위원 대한부인암중개연구회 연구분과위원 |
|
국제학회지 발표논문 1. Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women. J Korean Med Sci. 2015 Dec;30(12):1777-83. 2. Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics J Obstet Gynaecol Res. 2015 Dec 23. doi: 10.1111/jog.12915. [Epub ahead of print] 3. Detection of high-risk human papillomavirus using menstrual blood in women with high-grade squamous intraepithelial lesions or high-risk human papillomavirus infections: A pilot study J Obstet Gynaecol Res. 2015 Dec 2. doi: 10.1111/jog.12888. [Epub ahead of print] 4. Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance. Anticancer Res. 2015 Jul;35(7):3909-16 5. Matched-Case Comparisons in a Single Institution to Determine Critical Points for Inexperienced Surgeons' Successful Performances of Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Stage IA2-IIA Cervical Cancer PLoS One. 2015 Jun 25;10(6):e0131170. 6. Impact of age on the false negative rate of human papillomavirus DNA test in patients with atypical squamous cells of undetermined significance. Obstet Gynecol Sci. 2015 Mar;58(2):117-23 7. Laparoscopic ovarian surgery in children and adolescents JSLS. 2015 Jan-Mar;19(1):e2014.00253. 8. Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study. Med Sci Monit. 2014 Jul 30;20:1334-9 9. Surgical outcome and cost comparison between total vaginal hysterectomy and laparoscopic hysterectomy for uteri weighing >500 g J Minim Invasive Gynecol. 2014 Jan-Feb;21(1):115-9 10. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma. Med Sci Monit. 2013 Mar 29;19:230-5 11. Prognostic significance of perineural invasion in cervical cancer. Int J Gynecol Pathol. 2013 Mar;32(2):228-33 12. Comparison of two bipolar systems in laparoscopic hysterectomy. JSLS. 2012 Jul-Sep;16(3):456-60 13. Prophylactic adnexectomy along with vaginal hysterectomy for benign pathology Arch Gynecol Obstet. 2012 Nov;286(5):1221-5 14. Endocervical margin involvement as an important risk factor for abnormal cytology after LLETZ. Int J Gynecol Pathol. 2012 Jul;31(4):377-81. 15. When do we need to perform laparotomy for benign uterine disease? Factors involved with conversion in vaginal hysterectomy J Obstet Gynaecol Res. 2012 Jan;38(1):31-4 16. Primary extranodal marginal zone B-cell lymphoma of MALT-type involving the fallopian tube. Gynecol Oncol Case Rep. 2011 Oct 30;2(1):6-8 17. Factors determining conversion to laparotomy in patients undergoing total laparoscopic hysterectomy. Gynecol Obstet Invest. 2011;71(3):193-7 18. Comparison of clinical effects between total vaginal hysterectomy and total laparoscopic hysterectomy on large uteruses over 300 grams. J Obstet Gynaecol Res. 2010 Jun;36(3):656-60 19. Anti-Mullerian Hormone Changes Following Laparoscopic Ovarian Cystectomy: A Prospective Comparative Study Int J Womens Health. 2021 Jul 12;13:691-6982. 20. Comparison of Postoperative Ovarian Reserve Function Following Laparoscopic Hysterectomy and Laparoscopic Myomectomy: A Prospective Comparative Pilot Study J Clin Med 2021 Jul 12;10(14):30773. 21. Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells. Cancer Res Treat. 2021 Jul;53(3):819-8284. 22. CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis. Med Sci Monit 2019 Feb 9;25:1087-1092 |